Centre of Excellence in Materials-driven Solutions for Combatting Antimicrobial Resistance (MADNESS)

What we do

With antibiotic resistance on the rise and new drugs failing to meet the challenge, our mission is to combat antimicrobial resistance (AMR) and biofilms by pioneering advanced material-based treatment strategies against infectious diseases.

We leverage tailored nanoparticles as delivery systems for antimicrobial therapies, and extend our solutions to wound healing and tissue regeneration.

Read more

Upcoming events

Latest news

Xiaoju Wang became docent in Biomaterials Engineering

14.10.2024

Xiaoju Wang’s docentship in Biomaterials Engineering was recently granted by the Faculty of Science and Engineering at ÅAU.

PhD defence: Qingbo Wang

20.9.2024

PhD defence: Qingbo Wang On September 20th, 2024, MSc Qingbo Wang successfully defended his doctoral thesis entitled ‘Wood-Derived Functional Biomaterials towards 3D Bioprinting’. Docent Xiaoju Wang, PI in MADNESS, acted as the Custos and Dr. Gilberto De Freitas Siqueira from EMPA-Swiss Federal Laboratories was the respected opponent. Qingbo’s thesis work is a large part of…

Åbo Akademi University and Bayer will tackle bottlenecks in drug development

30.8.2024

Åbo Akademi University has received just over 195,000 euros in funding from The Finnish Research Impact Foundation for a project to develop small drug particles that can deliver the drug directly to the right place in the body.

7.8 M€ to NAP4DIVE Project for Advancing Non-Animal Drug Delivery Solutions

16.8.2024

7.8 M€ to NAP4DIVE Project for Advancing Non-Animal Drug Delivery Solutions During summer, we got the great news that our HORIZON-RIA proposal NAP4DIVE (Non-Animal Platform for Nanoparticle-Based Delivery across the blood-brain barrier Interface with Vehicle Evolution) had been granted in total 7.8 M€ funding from the EU. The project is an EU consortium comprising of…